Aplaket 250mg Tablet
Aplaket 250mg Tablet is an antiplatelet medicine or a blood thinner, which works by reducing the formation of harmful blood clots in blood vessels and thereby helps to prevent a stroke. It may also be prescribed along with aspirin to people who have undergone angioplasty (stent placement in blocked blood vessels of the heart). This helps to prevent blockage of a stent by blood clots.
Aplaket 250mg Tablet
Basic Information
Important information about this medicine
About This Medicine
General information about this product
Aplaket 250mg Tablet is a medicine used to prevent stroke in people for whom aspirin has failed to work or is not suitable. It lowers the chances of another stroke in people who have already suffered a stroke or a mini-stroke (brief stroke-like attack that resolves within a few minutes to hours).
Aplaket 250mg Tablet is an antiplatelet medicine or a blood thinner, which works by reducing the formation of harmful blood clots in blood vessels and thereby helps to prevent a stroke. It may also be prescribed along with aspirin to people who have undergone angioplasty (stent placement in blocked blood vessels of the heart). This helps to prevent blockage of a stent by blood clots.
It should be taken with food, preferably at the same time each day. It is important to keep taking this medicine regularly even if you feel well. If you stop taking this medicine, it may increase your chance of having a stroke.
The most common side effects of Ticlovil 250mg Tablet are nausea, vomiting, diarrhea, abdominal pain, rash, and decreased white blood cell count. Some people may develop bleeding as a side effect with this medicine, which may be in the form of bruising, nose bleeds, blood in urine or stools (black-colored stools), or heavier periods than usual in women. Consult your doctor straight away if the bleeding persists or worries you.
Aplaket 250mg Tablet is not suitable for some people. Do not take it if you are bleeding from anywhere in the body (such as a stomach ulcer or bleeding within the brain), have liver problems, or if you have blood formation-related problems (such as aplastic anemia and neutropenia). Your doctor will check your complete blood count (CBC) before starting this medicine and then monitor it periodically during treatment. This medicine may need to be stopped temporarily before planned surgery or dental treatment.
03Uses
Prevention of Stroke
04How To Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Aplaket 250mg Tablet is to be taken with food.
05How It Works
Aplaket 250mg Tablet is an antiplatelet medication. It works by preventing platelets from sticking together, thereby decreasing the formation of harmful blood clots. This lowers the chance of stroke or heart attack.
06What If You Miss A Dose?
If you miss a dose of Aplaket 250mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
07Benefits
In Prevention of Stroke
Aplaket 250mg Tablet is an antiplatelet medicine, or blood thinner. It works by preventing cells called platelets from sticking together and helps to prevent your blood from clotting inside veins and arteries. This helps the blood flow freely around your body thereby preventing a stroke. Take this medicine regularly and make appropriate lifestyle changes to achieve maximum benefits. It is often prescribed along with a low dose of aspirin which also helps to prevent blood from clotting.
08Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Decreased white blood cell count
Rash
Abdominal pain
Diarrhea
Vomiting
Nausea
09Safety Information
Alcohol:UNSAFE
It is unsafe to consume alcohol with Aplaket 250mg Tablet.
Pregnancy:SAFE IF PRESCRIBED
Aplaket 250mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding:CONSULT YOUR DOCTOR
Aplaket 250mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving:UNSAFE
Aplaket 250mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney:CONSULT YOUR DOCTOR
There is limited information available on the use of Aplaket 250mg Tablet in patients with kidney disease. Please consult your doctor.
Liver:CAUTION
Aplaket 250mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Aplaket 250mg Tablet may be needed. Please consult your doctor.Regular monitoring of liver function test is advisable while you are taking this medicine.
10Drug Tips
Take it with food to help you lower your chance of having an upset stomach like nausea and vomiting.
Do not discontinue using the medicine without consulting your doctor as this may increase your chances of having another heart attack or stroke.
You may be asked for regular blood tests to monitor CBC( complete blood count). Inform your doctor if you experience decreased white blood cells(WBC) and any infection.
Aplaket 250mg Tablet may lower your ability to fight off infections and make you more susceptible to them. Tell your doctor right away if you have any signs of infection (e.g., fever, cough, sore throat and chills)
References
Sources and references
Zehnder JL. Drugs Used in Disorders of Coagulation. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 598-99.
Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 344-45.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1361.
Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Hilal-Dandan R, Brunton LL, editors. Goodman and Gilman’s Manual of Pharmacology and Therapeutics. 2nd ed. New York: The McGraw-Hill Companies, Inc.; 2014. view
Ticlopidine. Toronto, Canada: Genpharm Inc.; 1999. view
Central Drugs Standard Control Organisation . view
